Sidley has advised HJ Science Co., Ltd. and Herbert Smith Freehills Kramer has advised CITIC Securities (Hong Kong) Limited as sole sponsor. HJ Science Co., Ltd....
HJ Science Raises HK$1.11 Billion in Hong Kong IPO
Softcare Raises HK$2.38 Billion in Hong Kong IPO
Sidley and DLA Piper have advised Softcare. Herbert Smith Freehills Kramer has advised the underwriters. Softcare Limited (Softcare) has completed its initial public offering and listing...
TS Lines’ IPO on Hong Kong Stock Exchange
Herbert Smith Freehills advised joint sponsors on T.S. Lines’ Hong Kong IPO. T.S. Lines Limited (02510.HK) completed its listing on the Main Board of the Hong...
MMG’s HK$9bn Rights Issue
Herbert Smith Freehills advised MMG on rights issue. MMG Limited (01208.HK) successfully completed a HK$9 billion rights issue, marking one of the largest equity fundraising efforts...
Hua Hong Semiconductor’s US$2.96 Billion IPO
Herbert Smith Freehills (HSF) acted as Hong Kong legal advisers to Hua Hong Semiconductor Limited (Hua Hong Semiconductor). Hua Hong Semiconductor has recently completed its initial...
MedSci Healthcare Holdings Limited’s Mainboard Listing on the Hong Kong Stock Exchange
Herbert Smith Freehills has advised China International Capital Corporation Hong Kong Securities Limited, and Macquarie Capital Limited. MedSci Healthcare operates one of the largest online professional...
Biocytogen Pharmaceuticals’ Listing on the Main Board of the Hong Kong Stock Exchange
Herbert Smith Freehills has advised Goldman Sachs and China International Capital Corporation as joint sponsors and underwriters. Biocytogen Pharmaceuticals (Beijing) Co., Ltd. announced the company’s official listing...